Tanina Foster Moore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tanina Foster Moore has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Dina George Lansey
Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
3 shared publications - Elisabeth I. Heath
Mayo Clinic Rochester Minnesota USA
3 shared publications - Lauren M. Hamel
Department of Oncology, Wayne State University School of Medicine, Detroit, MI
3 shared publications - Michael Anthony Carducci
Johns Hopkins School of Medicine Department of Oncology Baltimore, Maryland, 21287
3 shared publications - Susan Eggly
Wayne State University
3 shared publications - Ellen Barton
Linguistics Program, Department of English, Wayne State University, Detroit, USA
2 shared publications
Latest Publications
- Open Access
- 1 December 2022
- Published by Elsevier in PEC Innovation
- Vol. 1, 100012
Development and pilot test of a physician-focused cancer clinical trials communication training intervention
- 1 December 2022
- Published by Elsevier in PEC Innovation
- Vol. 1, 100012
Open AccessDevelopment and pilot test of a physician-focused cancer clinical trials communication training intervention
- 5 September 2022
- Published by Elsevier in Patient Education and Counseling
- Vol. 105 (12) , 3453-3458
Physicians’ use of plain language during discussions of prostate cancer clinical trials with patients
- 5 September 2022
- Published by Elsevier in Patient Education and Counseling
- Vol. 105 (12) , 3453-3458
Physicians’ use of plain language during discussions of prostate cancer clinical trials with patients
- Open Access
- 2 December 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 1-12
Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials
Cancer clinical trials are essential for testing new treatments and represent state-of-the-art cancer treatment, but only a small percentage of patients ever enroll in a trial. Under-enrollment is an even greater problem among minorities, particularly African Americans, representing a racial/ethnic disparity in cancer care. One understudied cause is patient-physician communication, which is often of poor quality during clinical interactions between African-American patients and non-African-American physicians. Partnering Around Cancer Clinical Trials (PACCT) involves a transdisciplinary theoretical model proposing that patient and physician individual attitudes and beliefs and their interpersonal communication during racially discordant clinical interactions influence outcomes related to patients’ decisions to participate in a trial. The overall goal of the study is to test a multilevel intervention designed to increase rates at which African-American and White men with prostate cancer make an informed decision to participate in a clinical trial. Data collection will occur at two NCI-designated comprehensive cancer centers. Participants include physicians who treat men with prostate cancer and their African-American and White patients who are potentially eligible for a clinical trial. The study uses two distinct research designs to evaluate the effects of two behavioral interventions, one focused on patients and the other on physicians. The primary goal is to increase the number of patients who decide to enroll in a trial; secondary goals include increasing rates of physician trial offers, improving the quality of patient-physician communication during video recorded clinical interactions in which trials may be discussed, improving patients’ understanding of trials offered, and increasing the number of patients who actually enroll. Aims are to 1) determine the independent and combined effects of the two interventions on outcomes; 2) compare the effects of the interventions on African-American versus White men; and 3) examine the extent to which patient-physician communication mediates the effect of the interventions on the outcomes. PACCT has the potential to identify ways to increase clinical trial rates in a diverse patient population. The research can also improve access to high quality clinical care for African American men bearing the disproportionate burden of disparities in prostate and other cancers. Clinical Trials.gov registration number: NCT02906241 (September 8, 2016).
- 2 December 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 1-12
Open AccessPartnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials
Cancer clinical trials are essential for testing new treatments and represent state-of-the-art cancer treatment, but only a small percentage of patients ever enroll in a trial. Under-enrollment is an even greater problem among minorities, particularly African Americans, representing a racial/ethnic disparity in cancer care. One understudied cause is patient-physician communication, which is often of poor quality during clinical interactions between African-American patients and non-African-American physicians. Partnering Around Cancer Clinical Trials (PACCT) involves a transdisciplinary theoretical model proposing that patient and physician individual attitudes and beliefs and their interpersonal communication during racially discordant clinical interactions influence outcomes related to patients’ decisions to participate in a trial. The overall goal of the study is to test a multilevel intervention designed to increase rates at which African-American and White men with prostate cancer make an informed decision to participate in a clinical trial. Data collection will occur at two NCI-designated comprehensive cancer centers. Participants include physicians who treat men with prostate cancer and their African-American and White patients who are potentially eligible for a clinical trial. The study uses two distinct research designs to evaluate the effects of two behavioral interventions, one focused on patients and the other on physicians. The primary goal is to increase the number of patients who decide to enroll in a trial; secondary goals include increasing rates of physician trial offers, improving the quality of patient-physician communication during video recorded clinical interactions in which trials may be discussed, improving patients’ understanding of trials offered, and increasing the number of patients who actually enroll. Aims are to 1) determine the independent and combined effects of the two interventions on outcomes; 2) compare the effects of the interventions on African-American versus White men; and 3) examine the extent to which patient-physician communication mediates the effect of the interventions on the outcomes. PACCT has the potential to identify ways to increase clinical trial rates in a diverse patient population. The research can also improve access to high quality clinical care for African American men bearing the disproportionate burden of disparities in prostate and other cancers. Clinical Trials.gov registration number: NCT02906241 (September 8, 2016).